Yoga and Cognitive Behavior Therapy Based Program to Promote Transition in Gynecologic Cancer Survivors - a Feasibility Study
Not Applicable
Recruiting
- Conditions
- Gynecological cancer (Uterine cancer, Cervical cancer, Uterine sarcoma, Ovarian cancer, Choriocarcinoma)
- Registration Number
- JPRN-UMIN000051805
- Lead Sponsor
- Japanese Red Cross Toyota College of Nursing
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1. Do not understand written or spoken Japanese 2. Diagnosis of mental disorder or cognitive impairment 3. Received yoga therapy or cognitive behavioral therapy 4. Plans to participate in other intervention study with gynecological cancer survivors in the near future
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Program participation rates
- Secondary Outcome Measures
Name Time Method 1. Simplified menopausal index 2. Cancer Concerns Checklist 3. Sense of Coherence-13 4. General Health Questionnaire-12 5. Salivary Cortisol 6. Heart rate, HF/LF 7. Blood pressure 8. Program acceptability 9. Adverse events
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of yoga and CBT in gynecologic cancer survivorship?
How does a yoga and CBT program compare to standard care in improving quality of life for gynecologic cancer survivors?
Are there specific biomarkers that predict response to mind-body interventions like yoga and CBT in ovarian or cervical cancer survivors?
What are the potential adverse events associated with integrating yoga and cognitive behavioral therapy in gynecologic cancer rehabilitation?
What combination approaches or pharmaceutical agents could enhance the outcomes of yoga and CBT programs for uterine sarcoma or choriocarcinoma survivors?